- TD Cowen downgraded BSX to Hold.
- Price target is $46.
- Previous rating was Buy.
TD Cowen cut Boston Scientific to Hold from Buy with a $46 price target. The downgrade signals reduced conviction in near-term upside for the med-tech stock.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.